229 related articles for article (PubMed ID: 26126533)
1. Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection.
Ramezani A; Dubrovsky L; Pushkarsky T; Sviridov D; Karandish S; Raj DS; Fitzgerald ML; Bukrinsky M
J Pharmacol Exp Ther; 2015 Sep; 354(3):376-83. PubMed ID: 26126533
[TBL] [Abstract][Full Text] [Related]
2. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1.
Morrow MP; Grant A; Mujawar Z; Dubrovsky L; Pushkarsky T; Kiselyeva Y; Jennelle L; Mukhamedova N; Remaley AT; Kashanchi F; Sviridov D; Bukrinsky M
Mol Pharmacol; 2010 Aug; 78(2):215-25. PubMed ID: 20479131
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.
Jiang H; Badralmaa Y; Yang J; Lempicki R; Hazen A; Natarajan V
Lipids Health Dis; 2012 Jul; 11():69. PubMed ID: 22676378
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
7. The effect of statins and the synthetic LXR agonist T0901317 on expression of ABCA1 transporter protein in human lung epithelial cell lines in vitro.
He P; Smith A; Gelissen IC; Ammit AJ
Pharmacol Rep; 2019 Dec; 71(6):1219-1226. PubMed ID: 31669886
[TBL] [Abstract][Full Text] [Related]
8. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
[TBL] [Abstract][Full Text] [Related]
10. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
11. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection.
Dubrovsky L; Van Duyne R; Senina S; Guendel I; Pushkarsky T; Sviridov D; Kashanchi F; Bukrinsky M
Biochem Biophys Res Commun; 2012 Mar; 419(1):95-8. PubMed ID: 22326260
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
[TBL] [Abstract][Full Text] [Related]
14. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.
Ramírez CM; Rotllan N; Vlassov AV; Dávalos A; Li M; Goedeke L; Aranda JF; Cirera-Salinas D; Araldi E; Salerno A; Wanschel A; Zavadil J; Castrillo A; Kim J; Suárez Y; Fernández-Hernando C
Circ Res; 2013 Jun; 112(12):1592-601. PubMed ID: 23519695
[TBL] [Abstract][Full Text] [Related]
15. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
[TBL] [Abstract][Full Text] [Related]
16. Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.
Ku CS; Park Y; Coleman SL; Lee J
J Nutr Biochem; 2012 Oct; 23(10):1271-6. PubMed ID: 22209005
[TBL] [Abstract][Full Text] [Related]
17. Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.
Loane DJ; Washington PM; Vardanian L; Pocivavsek A; Hoe HS; Duff KE; Cernak I; Rebeck GW; Faden AI; Burns MP
J Neurotrauma; 2011 Feb; 28(2):225-36. PubMed ID: 21175399
[TBL] [Abstract][Full Text] [Related]
18. Activation of liver X receptor induces macrophage interleukin-5 expression.
Chen Y; Duan Y; Kang Y; Yang X; Jiang M; Zhang L; Li G; Yin Z; Hu W; Dong P; Li X; Hajjar DP; Han J
J Biol Chem; 2012 Dec; 287(52):43340-50. PubMed ID: 23150660
[TBL] [Abstract][Full Text] [Related]
19. LXR Agonism Upregulates the Macrophage ABCA1/Syntrophin Protein Complex That Can Bind ApoA-I and Stabilized ABCA1 Protein, but Complex Loss Does Not Inhibit Lipid Efflux.
Tamehiro N; Park MH; Hawxhurst V; Nagpal K; Adams ME; Zannis VI; Golenbock DT; Fitzgerald ML
Biochemistry; 2015 Nov; 54(46):6931-41. PubMed ID: 26506427
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
